. Author manuscript; available in PMC: 2012 Apr 1.

Published in final edited form as: Arch Dermatol. 2010 Dec 20;147(4):419–424. doi: 10.1001/archdermatol.2010.370

Table 3.

Prevalence of Individual Metabolic Abnormalities of the Metabolic Syndrome According to Presence of Psoriasis in the National Health and Nutrition Examination Survey (NHANES), 2003–2006^a

Variable	% (95% CI)		OR^b (95% CI)
Variable	Psoriasis	No Psoriasis	OR^b (95% CI)
Abdominal obesity	62.9 (51.3 – 74.5)	47.9 (45.3 – 50.5)	1.72 (1.03 – 2.86)
Hypertriglyceridemia	44 (33.8 – 54.2)	27.2 (24.9 – 29.6)	2.08 (1.39 – 3.11)
Low HDL cholesterol	33.9 (23.7 – 44.1)	23.9 (21.3 – 26.4)	1.63 (0.98 – 2.71)
High blood pressure	28.4 (14.8 – 41.9)	22.2 (20.4 – 24)	1.33 (0.63 – 2.79)
High fasting glucose (original)	8.4 (1.4 – 15.4)	8.0 (6.5 – 9.4)	1.01 (0.44 – 2.36)
High fasting glucose (modified)	30.5 (16.9 – 44.1)	28.5 (25 – 32)	1.06 (0.56 – 1.99)

Abbreviations: CI, confidence interval; HDL, high-density lipoprotein; OR, odds ratio.

Data are presented incorporating sample weights and adjusted for clusters and strata of the complex sample design of NHANES.

Odds ratios are adjusted for age, sex, and race/ethnicity.